Cyclooxygenase-2 inhibition increases gastric tone and delays gastric emptying in rats

Neurogastroenterology and Motility

Volumn 19, Issue 3, 2007, Pages 225-232

  Santos, C L ^a   Medeiros, B A ^a   Palheta Jr , R C ^a   Macedo, G M ^a   Nobre E Souza, M A ^a   Troncon, L E A ^b   Santos, A A ^a   Souza, M H L P ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

COX 2; Gastric emptying; Gastric tone

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSE; INDOMETACIN; KETOROLAC; PHENOLSULFONPHTHALEIN; ROFECOXIB; SODIUM CHLORIDE; VALDECOXIB;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; MALE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; STOMACH EMPTYING; STOMACH MUSCLE; TEST MEAL;

ANIMALS; CYCLOOXYGENASE 2 INHIBITORS; GASTRIC EMPTYING; GASTRIC MUCOSA; INDOMETHACIN; ISOXAZOLES; KETOROLAC; LACTONES; MALE; MUSCLE, SMOOTH; PYRAZOLES; RATS; RATS, WISTAR; STOMACH; SULFONAMIDES; SULFONES;

EID: 33846900164     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.00913.x     Document Type: Article

References (28)

1. Takeuchi K, Takehara K, Ohuchi T. Diethyldithiocarbamate, a superoxide dismutase inhibitor, reduces indomethacin-induced gastric lesions in rats. Digestion 1996; 57: 201-9.
2. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114-22.
3. Ueki S, Takeuchi K, Okabe S. Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 1988; 33: 209-16.
4. Fioramonti J, Bueno L. Gastrointestinal myoelectric activity disturbances in gastric-ulcer disease in rats and dogs. Dig Dis Sci 1980; 25: 575-80.
5. Souza MH, Troncon LE, Cunha FQ, Oliveira RB. Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Braz J Med Biol Res 2003; 36: 1383-90.
6. Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995; 109: 285-301.
7. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004; 18: 790-804.
8. Porcher C, Horowitz B, Bayguinov O, Ward SM, Sanders KM. Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles. Gastroenterology 2002; 122: 1442-54.
9. Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL. Aspirin causes rapid up-regulation of cyclooxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997; 11: 1101-8.
10. Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase-2 by antiinflammatory agents. Nature (Lond) 1996; 384: 644-8.
11. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000; 119: 706-14.
12. Souza MH, de Lima OM Jr, Zamuner SR, Fiorucci S, Wallace JL. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2mediated lipoxin synthesis. Am J Physiol Gastrointest Liver Physiol 2003; 285: 54-61.
13. Alsalameh S, Burian M, Mahr G, Woodcock BG, Geisslinger G. The pharmacological properties and clinical use of valdecoxib, a new cyclooxygenase-2-selective inhibitor. Aliment Pharmacol Ther 2003; 17: 489-501.
14. Reynell PC, Spray GH. The simultaneous measurement of absorption and transit in the gastrointestinal tract of the rat. J Physiol 1956; 131: 452-62.
15. Santucci L, Fiorucci S, Giansanti M. Pentoxifylline prevents indomethacin-induced acute gastric mucosal damage in rats - role of tumor necrosis factor-alpha. Gut 1994; 35: 909-15.
16. Graca JRV, Leal PRL, Gondim FA, Rola FH, Santos AA. A Plethysmometric method for gastric compliance studies in anesthetized rats. J Pharmacol Toxicol Methods 2000; 43: 25-30.
17. Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol (Paris) 2001; 95: 21-7.
18. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal antiinflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 2002; 303: 1248-54.
19. Porcher C, Horowitz B, Ward SM, Sanders KM. Constitutive and functional expression of cyclooxygenase2 in the murine proximal colon. Neurogastroenterol Motility 2004; 16: 785-99.
20. Fornai M, Blandizzi C, Colucci R et al. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut 2005; 54: 608-16.
21. Haba T, Sarna SK. Regulation of gastroduodenal emptying of solids by gastropyloroduodenal contractions. Am J Physiol 1993; 264: G261-71.
22. Gondim FA, Oliveira GR, Graca JR, Gondim RB, Alencar HM, Dantas RP, Santos AA, Rola FH. Neural mechanisms involved in the delay of gastric emptying of liquid elicited by acute blood volume expansion in awake rats. Neurogastroenterol Motil 1999; 11: 93-9.
23. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 2004; 16: 729-35.
24. Petring OU, Dawson PJ, Blake DW, Jones DJ, Bjorksten AR, Libreri FC, Leadbeater M. Normal postoperative gastric emptying after orthopaedic surgery with spinal anaesthesia and i.m. ketorolac as the first postoperative analgesic. Br J Anaesth 1995; 74: 257-60.
25. Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Dig Dis Sci 2004; 49: 180-7.
26. Scarpignato C, Capovilla T, Bertaccini G. Action of caerulein on gastric emptying of the conscious rat. Arch Int Pharmacodyn Ther 1980; 246: 286-94.
27. Barnett K, Bell CJ, McKnight W, Dicay M, Sharkey KA, Wallace JL. Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach. Am J Physiol 2000; 279: G1292-7.
28. Day R, Morrison B, Luza A et al. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch Intern Med 2000; 160: 1781-7.